SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients-Reference-Cited by-同舟云学术

SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients

Published:2022-01 Issue:1 Volume:20 Page:162-172.e9
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Ruether Darius F.,Schaub Golda M.,Duengelhoef Paul M.,Haag Friedrich,Brehm Thomas T.,Fathi Anahita,Wehmeyer Malte,Jahnke-Triankowski Jacqueline,Mayer Leonie,Hoffmann Armin,Fischer Lutz,Addo Marylyn M.,Lütgehetmann Marc,Lohse Ansgar W.,Schulze zur Wiesch Julian,Sterneck Martina

Funder

Deutsches Zentrum für Infektionsforschung

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

2. C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020

3. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: an international registry study;Marjot;J Hepatol,2021

4. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study;Webb;Lancet Gastroenterol Hepatol,2020

5. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients;Boyarsky;JAMA,2021

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune response against bacterial infection in organ transplant recipients;Transplant Immunology;2024-10

2. Evaluation of SARS-CoV-2 anti-Spike antibody levels and breakthrough infection risk among vaccinated adults in North Lebanon;PLOS ONE;2024-05-09

3. COVID-19 in Individuals with Chronic Liver Diseases;Journal of Gastrointestinal and Liver Diseases;2024-03-29

4. Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis;Human Vaccines & Immunotherapeutics;2024-03-11

5. Advancements in Vaccine Strategies for Chronic Liver Disease Patients: Navigating Post-COVID Challenges and Opportunities;Vaccines;2024-02-15